Ausgewählte Publikationen

Ausgewählte Publikationen:

1) Schmidt, D., Nayak, A., Schumann, J.E., Schimpl, A., Berberich, I., and Berberich-Siebelt, F. (2008). Blimp-1Δexon7: a naturally occurring Blimp-1 deletion mutant with auto-regulatory potential. Exp Cell Res 314, 3614-3627 (shared senior authorship).

2) Herold, M.J., Zeitz, J., Pelzer, C., Kraus, C., Peters, A., Wohlleben, G., and Berberich, I. (2006). The stability and anti-apoptotic function of A1 are controlled by its C terminus. J Biol Chem 281, 13663-13671.

3) Berberich-Siebelt, F., Berberich, I., Andrulis, M., Santner-Nanan, B., Jha, M.K., Klein-Hessling, S., Schimpl, A., and Serfling, E. (2006). SUMOylation interferes with CCAAT/enhancer-binding protein beta-mediated c-myc repression, but not IL-4 activation in T cells. J Immunol 176, 4843-4851.

4) Tarte, K., Jourdan, M., Veyrune, J.L., Berberich, I., Fiol, G., Redal, N., Shaughnessy, J., Jr., and Klein, B. (2004). The Bcl-2 family member Bfl-1/A1 is strongly repressed in normal and malignant plasma cells but is a potent anti-apoptotic factor for myeloma cells. Brit J Haematol 125, 373-382.

5) Herold, M.J., Kuss, A.W., Kraus, C., and Berberich, I. (2002). Mitochondria-dependent caspase-9 activation is necessary for antigen receptor-mediated effector caspase activation and apoptosis in WEHI 231 lymphoma cells. J Immunol 168, 3902-3909.